Since the production of proinflammatory cytokines is increased in rheumatoid arthritis (RA), it has been proposed that the increase in cytokines including IFN-γ and IL-6 could drive the observed decrease in GRK2 expression and activity in MNLs isolated from RA patients [12]. This evidence concerns the gene GRK2 and rheumatoid arthritis.